ZURICH, April 14 (Reuters) - Swiss generic drug manufacturer Sandoz (SDZ.S), opens new tab said on Monday it had filed an antitrust lawsuit in the United States against Amgen (AMGN.O), opens new ...

Sandoz has filed an antitrust lawsuit in the United States against Amgen, for extending and entrenching the dominant market position of its blockbuster medicine, Enbrel (etanercept). The drug was ...

Alston & Bird represent plaintiff Sandoz Inc. in an antitrust lawsuit against Amgen. Munger, Tolles & Olson and Kaufman & Canoles represent Amgen in a related case in the Eastern District of Virginia.

Hoping to alter the timetable is Swiss generics and biosimilars specialist Sandoz, which has filed an antitrust lawsuit in federal court in Virginia claiming that Amgen has blocked competition to ...

Sandoz has filed an antitrust lawsuit in the US against Amgen, challenging alleged anti-competitive practices surrounding the biologic blockbuster Enbrel (etanercept). Filed at the US District ...

Spain's competition watchdog opened an investigation into whether drug makers including Sandoz and its subsidiary Bexal broke antitrust rules by sharing sensitive commercial information.

ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen over the alleged entrenchment of the market position of ...

Submitted on Friday, Sandoz's lawsuit alleged Amgen has used a "thicket of patents" to protect its monopoly for Enbrel through 2029 in violation of U.S. federal antitrust law. Filed in a Norfolk ...